CO2023012852A2 - Moléculas inhibidoras de tirosinasa y composición dermofarmaceútica o cosmética que las incluye - Google Patents

Moléculas inhibidoras de tirosinasa y composición dermofarmaceútica o cosmética que las incluye

Info

Publication number
CO2023012852A2
CO2023012852A2 CONC2023/0012852A CO2023012852A CO2023012852A2 CO 2023012852 A2 CO2023012852 A2 CO 2023012852A2 CO 2023012852 A CO2023012852 A CO 2023012852A CO 2023012852 A2 CO2023012852 A2 CO 2023012852A2
Authority
CO
Colombia
Prior art keywords
dermopharmaceutical
cosmetic composition
inhibitor molecules
tyrosinase inhibitor
tyrosinase
Prior art date
Application number
CONC2023/0012852A
Other languages
English (en)
Inventor
Del Prado Sergio Pascual
Junqué Alexandra Bertran
Rodríguez María Del Carmen González
García Luís Shotze Luis
Gutiérrez Alfredo Martínez
Original Assignee
Mesoestetic Pharma Group S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mesoestetic Pharma Group S L filed Critical Mesoestetic Pharma Group S L
Publication of CO2023012852A2 publication Critical patent/CO2023012852A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/44—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing doubly-bound oxygen atoms bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención proporciona moléculas inhibidoras de tirosinasa de fórmula general (I), así como una composición dermofarmacéutica o cosmética que incluye al menos una de dichas moléculas inhibidoras de tirosinasa.
CONC2023/0012852A 2021-04-01 2023-09-28 Moléculas inhibidoras de tirosinasa y composición dermofarmaceútica o cosmética que las incluye CO2023012852A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2021/070225 WO2022129651A1 (es) 2021-04-01 2021-04-01 Moléculas inhibidoras de tirosinasa y composición dermofarmaceútica o cosmética que las incluye

Publications (1)

Publication Number Publication Date
CO2023012852A2 true CO2023012852A2 (es) 2023-10-09

Family

ID=76098968

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2023/0012852A CO2023012852A2 (es) 2021-04-01 2023-09-28 Moléculas inhibidoras de tirosinasa y composición dermofarmaceútica o cosmética que las incluye

Country Status (5)

Country Link
EP (1) EP4223740A1 (es)
AU (1) AU2021403876A1 (es)
CO (1) CO2023012852A2 (es)
WO (1) WO2022129651A1 (es)
ZA (1) ZA202307066B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1267868B1 (en) 2000-02-29 2007-07-18 MediQuest Therapeutics, Inc. Inhibitors of melanocyte tyrosinase as topical skin lighteners
EP1967176A1 (en) 2007-03-06 2008-09-10 Cognis IP Management GmbH Use of derivatives of 4-Hydroxyphenoxy acetic acid
KR101663576B1 (ko) * 2014-09-23 2016-10-10 바이오스펙트럼 주식회사 플로레틴 술폰산염 및 이를 포함하는 피부 상태 개선용 조성물

Also Published As

Publication number Publication date
ZA202307066B (en) 2024-04-24
AU2021403876A1 (en) 2023-07-20
EP4223740A1 (en) 2023-08-09
WO2022129651A1 (es) 2022-06-23

Similar Documents

Publication Publication Date Title
CL2018002703A1 (es) Agentes de iarn, composiciones y métodos de uso de los mismos para tratar enfermedades asociadas con transtiretina (ttr). (divisional solicitud 201401291)
BR112021024224A2 (pt) Inibidores de tead e usos dos mesmos
CO2022010098A2 (es) Inhibidores de proteínas kras mutantes
MD3864003T2 (ro) Modulatori de promedicamente ai căii integrate de răspuns la stres
MD3452448T2 (ro) Modulatori ai răspunsului integrat la stres
NI202100018A (es) Moduladores de la expresión de pnpla3
HN2006018410A (es) Nuevos derivados del fluoreno, composiciones que los contienen y utilizacion
CR10680A (es) Composiciones de inhibidores de chk1
NI202000085A (es) Moduladores de la expresión de apol1
BR112022008294A2 (pt) Composições de profármaco e métodos de tratamento
CR20190471A (es) Moduladores de la expresión de pcsk9
BR112021025534A2 (pt) Composição cosmética para o tingimento oxidativo de fibras de queratina
CO2022000481A2 (es) Inhibidores de enzimas
PE20210109A1 (es) Moduladores de la expresion de irf4
CO2023007008A2 (es) Moduladores de la vía integrada del estrés
BR112022021562A2 (pt) Partículas interferentes terapêuticas para o coronavírus
BR112022018678A2 (pt) Degradadores de mdm2 e usos dos mesmos
BR112022017192A2 (pt) Variantes de transglutaminase
BR112023018619A2 (pt) Inibidores de heteroaril de calicreína plasmática
AR117094A1 (es) Moduladores de expresión irf5
BR112023023223A2 (pt) Degradadores de cdk2 e usos dos mesmos
CO2022003742A2 (es) Conjugados de interleuquina 10 y sus usos
BR112019001158A2 (pt) formas de succinato e composições de inibidores da tirosina quinase de bruton
CO2024001143A2 (es) Mezclas insecticidas
UY38472A (es) Moduladores de la expresión de foxp3